UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin

Journal of experimental therapeutics & oncology, 2017-05, Vol.12 (1), p.1-7

2017

Volltextzugriff (PDF)

Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E

Journal of experimental therapeutics & oncology, 2009, Vol.8 (2), p.129-144

2009

Volltextzugriff (PDF)

The reversal of multidrug resistance: an update

Journal of experimental therapeutics & oncology, 2003-01, Vol.3 (1), p.5-13

Kellen, John A.

2003

Volltextzugriff (PDF)

P-170 peptides with low similarity to the human proteome: tracing an effective and safe biological way towards effective and safe cancer chemotherapy

Journal of experimental therapeutics & oncology, 2009, Vol.8 (2), p.151

2009

Volltextzugriff (PDF)

Dynamic heterogeneity of proteomic expression in human cancer cells does not affect Cdk1/Cdk4 co-expression

Journal of experimental therapeutics & oncology, 2008, Vol.7 (3), p.237-254

2008

Volltextzugriff (PDF)

Ephrin type-B receptor 4 is an essential mediator in drug-resistance of acute myeloid leukemia cells to Adriamycin

Journal of experimental therapeutics & oncology, 2018-11, Vol.12 (4), p.249

2018

Volltextzugriff (PDF)

Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells

Journal of experimental therapeutics & oncology, 2012, Vol.10 (1), p.9-18

2012

Volltextzugriff (PDF)

A novel strategy of cancer therapy by enucleation

Journal of experimental therapeutics & oncology, 2012, Vol.10 (2), p.113-117

Guddati, Achuta K

2012

Volltextzugriff (PDF)

Roscovitine, a small molecule CDK inhibitor induces apoptosis in multidrug-resistant human multiple myeloma cells

Journal of experimental therapeutics & oncology, 2011, Vol.9 (1), p.27-35

2011

Volltextzugriff (PDF)

Bortezomib as a therapeutic candidate for neuroblastoma

Journal of experimental therapeutics & oncology, 2008, Vol.7 (2), p.135

2008

Volltextzugriff (PDF)

Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation

Journal of experimental therapeutics & oncology, 1996-01, Vol.1 (1), p.39-48

1996

Volltextzugriff (PDF)

Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system

Journal of experimental therapeutics & oncology, 2006, Vol.6 (1), p.1

2006

Volltextzugriff (PDF)

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer

Journal of experimental therapeutics & oncology, 2004-07, Vol.4 (2), p.155-160

2004

Volltextzugriff (PDF)

Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides

Journal of experimental therapeutics & oncology, 2002-01, Vol.2 (1), p.37-41

2002

Volltextzugriff (PDF)

Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice

Journal of experimental therapeutics & oncology, 2003-03, Vol.3 (2), p.72-82

2003

Volltextzugriff (PDF)

Effects of etherlipid analogs on cell membrane functions

Journal of experimental therapeutics & oncology, 2003-07, Vol.3 (4), p.185-193

2003

Volltextzugriff (PDF)

Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells

Journal of experimental therapeutics & oncology, 2003-05, Vol.3 (3), p.127-135

2003

Volltextzugriff (PDF)

Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells

Journal of experimental therapeutics & oncology, 2002-03, Vol.2 (2), p.85-92

2002

Volltextzugriff (PDF)

P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs

Journal of experimental therapeutics & oncology, 2002-06, Vol.2 (3), p.146-152

Galmarini, Carlos M.

2002

Volltextzugriff (PDF)

Preclinical anticancer activity of cryptophycin-8

Journal of experimental therapeutics & oncology, 1996-03, Vol.1 (2), p.95

1996

Volltextzugriff (PDF)

Parameters affecting the ex vivo cytotoxic drug sensitivity of human hematopoietic cells

Journal of experimental therapeutics & oncology, 2002-01, Vol.2 (1), p.53-63

2002

Volltextzugriff (PDF)

Modulation of chemosensitivity in human colon carcinoma cells by downregulating protein kinase C alpha expression

Journal of experimental therapeutics & oncology, 1996-07, Vol.1 (4), p.218-221

1996

Volltextzugriff (PDF)

Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells

Journal of experimental therapeutics & oncology, 1996-09, Vol.1 (5), p.278-285

1996

Volltextzugriff (PDF)

Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues

Journal of experimental therapeutics & oncology, 1996-11, Vol.1 (6), p.368-375

1996

Volltextzugriff (PDF)

Multidrug resistance-modifying components in human plasma with potential clinical significance

Journal of experimental therapeutics & oncology, 1996-01, Vol.1 (1), p.13-22

1996

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

ThemaMedical Sciences

KollektionOld City Publishing

KollektionWiley Online Library

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Kollektion

Zeitschrift / Serie

Journal Of Experimental Therapeutics & Oncology
(34)

Menü

Weitere Dienste

Einstellungen

Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin

Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E

The reversal of multidrug resistance: an update

P-170 peptides with low similarity to the human proteome: tracing an effective and safe biological way towards effective and safe cancer chemotherapy

Dynamic heterogeneity of proteomic expression in human cancer cells does not affect Cdk1/Cdk4 co-expression

Ephrin type-B receptor 4 is an essential mediator in drug-resistance of acute myeloid leukemia cells to Adriamycin

Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells

A novel strategy of cancer therapy by enucleation

Roscovitine, a small molecule CDK inhibitor induces apoptosis in multidrug-resistant human multiple myeloma cells

Bortezomib as a therapeutic candidate for neuroblastoma

Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation

Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer

Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides

Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice

Effects of etherlipid analogs on cell membrane functions

Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells

Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells

P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs

Preclinical anticancer activity of cryptophycin-8

Parameters affecting the ex vivo cytotoxic drug sensitivity of human hematopoietic cells

Modulation of chemosensitivity in human colon carcinoma cells by downregulating protein kinase C alpha expression

Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells

Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues

Multidrug resistance-modifying components in human plasma with potential clinical significance

Aktive Filter

Suchergebnisse filtern